Technology developer Cambridge Consultants has created a new diagnostic platform that could improve sensitivity for near-patient and point-of-care (POC) testing. The platform, developed in collaboration with XenBio Fluidics, is based on a new label and a "very sensitive, very ...
Please Login to read the full article.
